Combination drug approach aims to tame immune attack after stem cell transplant
NCT ID NCT05443425
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This trial tests whether adding leflunomide to standard steroid therapy can safely control acute graft-versus-host disease (aGVHD) in people who have had a stem cell transplant for blood cancer. aGVHD occurs when donor immune cells attack the patient's own body. Leflunomide and steroids both suppress the immune system but work in different ways. The study enrolls adults with moderate to severe aGVHD and primarily monitors side effects and treatment response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Leflunomide (Arava) plus steroids
- What this could lead to
- If it works, this combination could offer a new way to control graft-versus-host disease, reducing the need for high-dose steroids and their side effects.
- What could go wrong
- This is a small, early-phase trial focused on safety, not yet proven to work. Leflunomide may cause side effects like liver problems or infections, and the combination may not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New shot may shield transplant patients from deadly immune attack
- Can talking about stress ease Cancer's mental toll? new study aims to find out
- New drug shows promise in controlling transplant complications
- New program aims to close the gap in cancer trial diversity
- Mayo clinic hunts for hidden cancer clues in DNA and proteins
- Poop pills may tame deadly transplant complication